Vimarsana
Biggest News Aggregation in the World

Page 13 - Groupb Streptococcus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Groupb Streptococcus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Groupb Streptococcus Today - Breaking & Trending Today

The Current and Future Landscape of Maternal Immunisation - Vimarsana News

The Current and Future Landscape of Maternal Immunisation

Vaccinating women in pregnancy can protect women and their infants from infectious diseases. This intervention is increasingly recognised as a safe and effective way to reduce infant morbidity and mortality.  

MinervaX Commences First Phase 1 Clinical Study of Novel GBS Vaccine in Older Adults - Vimarsana News

MinervaX Commences First Phase 1 Clinical Study of Novel GBS Vaccine in Older Adults

/PRNewswire/ -- MinervaX ApS, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), announces the first...

Oklahoma health officials say the public health lab needs more money - Vimarsana News

Oklahoma health officials say the public health lab needs more money

Lawmakers are planning to invest $3-9 million more in the facility to up its biosafety rating.

Source: kosu.org
Maternal Immunization and Pregnancy Vaccination Stories | Bill & Melinda Gates Foundation - Vimarsana News

Maternal Immunization and Pregnancy Vaccination Stories | Bill & Melinda Gates Foundation

Learn about medical professionals and families whose stories illustrate how far this field has come—and how much more progress is needed.

Global Molecular Point of Care (mPOC) Market Report 2023-2027: Market Sizing, Forecasting, Trend Mapping and Competitive Analysis - Vimarsana News

Global Molecular Point of Care (mPOC) Market Report 2023-2027: Market Sizing, Forecasting, Trend Mapping and Competitive Analysis

The "The Market and Future Potential for Molecular Point of Care (mPOC), 2023" report has been added to ResearchAndMarkets.com's offering. This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular...